Global Infectious Disease Therapeutics Market

Infectious Disease Therapeutics Market Size, Share, Growth Analysis, By Mode of treatment(Vaccines and drugs), By Target organism (Antiviral, antifungal, antibacterial, anti-parasite), By Infection type(Parasitic, viral, fungal, bacterial), By Distribution channel(Hospitals, clinics, and others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35J2030 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 119 |Figures: 77

Infectious Disease Therapeutics Market Insights

Infectious Disease Therapeutics Market size was valued at USD 115 billion in 2019 and is poised to grow from USD 119.86 billion in 2023 to USD 166.97 billion by 2031, growing at a CAGR of 4.23% in the forecast period (2024-2031).

Infectious disease is a major cause of significant pressure in the global healthcare industry. These diseases, also known as transmissible or communicable diseases, are caused by a variety of infectious agents such as viruses, viroids, and bacteria. The introduction of various technologically advanced diagnosis and treatment options, as well as advancements in hygiene, vaccination, and antimicrobial therapy, have reduced the number of deaths caused by infectious diseases. However, the rise and re-emergence of infectious diseases have a significant impact on the global population's health outcomes. The infectious disease therapeutics market is anticipated to grow significantly over the forecast period, attributed to rising infectious disease occurrence, increased awareness about early infectious disease diagnosis, and increased research funding activities by various private and government organisations. However, the high cost of treating infectious diseases with highly developed medicines severely restricts market growth by putting additional strain on people's disposable income. The market's increasing demand for generic drugs has also hampered the growth of labelled drugs that treat infectious diseases.

US Infectious Disease Therapeutics Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 115 billion

Largest Segment

Drugs

Fastest Growth

Drugs

Growth Rate

4.23% CAGR

Global Infectious Disease Therapeutics Market, 2021-2028 ($ Bn)
Country Share for North America Region- 2021 (%)

To get more reports on the above market click here to Buy The Report

Infectious Disease Therapeutics Market Segmental Analysis

Global Infectious Disease Therapeutics Market is segmented based on the mode of treatment, target organism, infection type, distribution channel, and region. Based on mode of treatment, global Infectious Disease Therapeutics Market is segmented into vaccines, and drugs. Based on target organism, the global Infectious Disease Therapeutics Market is segmented into antiviral, antifungal, antibacterial, anti-parasite, and others. Based on infection type, global Infectious Disease Therapeutics Market is segmented into parasitic, viral, fungal, bacterial, and others. Based on distribution channel, global Infectious Disease Therapeutics Market is segmented into hospitals, clinics, and others. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Infectious Disease Therapeutics Market Analysis by Mode of Treatment

Based on mode of treatment, global infectious disease therapeutics market is segmented into vaccines, and drugs. Due to the increasing demand for advanced drugs in the market, the drug segment is expected to hold the largest share in the market and to grow at the fastest rate during the forecast timeframe. Because it is the most common line of treatment for these people, the large number of people in the geriatric population has emerged as a significant opportunity for the drug segment.

Vaccines are also gaining traction in the market as it has become a common entity from the time a child is born until new diseases and vaccinations are introduced into the market.

Infectious Disease Therapeutics Market Analysis by Target Organism

Based on target organism, the global infectious disease therapeutics market is segmented into antiviral, antifungal, antibacterial, anti-parasite, and others. Due to the increasing prevalence of diseases spread by bacteria, the antibacterial segment is expected to hold the largest market and grow at the fastest rate during the forecast timeframe. Furthermore, diseases like hepatitis A, influenza, tuberculosis, HIV, and hepatitis C are becoming more common. Merged as a significant opportunity for the anti-bacterial segment growth during the forecast period.

Global Infectious Disease Therapeutics Market By Mode of treatment, 2021 (%), 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Infectious Disease Therapeutics Market Regional Insights

North America held the largest global infectious disease therapeutics market share in 2021 due to the region's growing rate of infectious diseases. This region's large geriatric population has emerged as a significant growth factor for the market during the forecast period. People's increased disposable income has also become an important growth factor. The government's provision of advanced health-care facilities in the form of reimbursement policies has greatly aided market growth. Moreover, the existence of key manufacturers in the United States, as well as an increase in clinical trials for the introduction of new treatment drugs, are estimated to generate to this region's large market share.

Due to the growing occurrence of infectious diseases and increasing expenditure on the prevention and diagnosis of infectious diseases, Asia Pacific is projected to expand at the fastest CAGR during the forecast period.

Global Infectious Disease Therapeutics Market By Geography, 2021-2028, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Infectious Disease Therapeutics Market Dynamics

Infectious Disease Therapeutics Market Driver

  • Increased spending to enhance the penetration rate of infectious disease treatments, rising strategies to raise awareness about treatments and diagnosis of these conditions, and increased clinical trial research for the development of new drugs may drive the growth of global infectious disease therapeutics market over the forecast period.

Infectious Disease Therapeutics Market Restraint 

  • Inadequate knowledge about treatments available for disorders, as well as low treatment adoption and reimbursement for certain infectious diseases in developing countries, may limit the growth of the infectious disease therapeutics market over the forecast period.

Request Free Customization of this report to help us to meet your business objectives.

Infectious Disease Therapeutics Market Competitive Landscape

Global infectious disease therapeutics market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.

Infectious Disease Therapeutics Market Top Player's Company Profiles  

  • GlaxoSmithKline plc
  • Merck & Co.
  • Pfizer Inc.
  • Roche Holding AG
  • Novartis AG
  • Sanofi S.A.
  • Johnson & Johnson
  • AstraZeneca plc
  • AbbVie Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • Bayer AG
  • Novo Nordisk A/S
  • Takeda Pharmaceutical Co. Ltd.
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • Allergan plc
  • Celgene Corporation

Infectious Disease Therapeutics Market Recent Developments

  • In November 2022, NRG Therapeutics, Ltd. announced £16 million Series A for advancing mitochondrial therapeutics for Parkinson's and ALS.
  • In October 2022, Seres Therapeutics, Inc., a leading microbiome therapeutics company, announces that the FDA has accepted for priority review its Biologics License Application for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection.

Infectious Disease Therapeutics Key Market Trends

  • Increasing prevalence of malaria disease in developing and underdeveloped countries including India, Africa, and other Southeast Asian countries, as well as increased research and development activities by key manufacturers and health care organisations, are all contributing to market development.

Infectious Disease Therapeutics Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.

According to our global infectious disease therapeutics market analysis, the increased emphasis of governments in Asia Pacific countries on infection prevention and raising funds to increase the implementation of treatments for infectious diseases is projected to drive the demand during the forecast period. The growing spread of malaria in various countries, as well as increased research and development activities, are projected to augment for infectious disease drugs, boosting market growth. However, during the analysis period, a shortage of skilled professionals may severely impede the growth of the market.

Report Metric Details
Market size value in 2023 USD 115 billion
Market size value in 2031 USD 166.97 billion
Growth Rate 4.23%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Mode of treatment
    • Vaccines and drugs
  • Target organism 
    • Antiviral, antifungal, antibacterial, anti-parasite, and others
  • Infection type
    • Parasitic, viral, fungal, bacterial, and others
  • Distribution channel
    • Hospitals, clinics, and others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • GlaxoSmithKline plc
  • Merck & Co.
  • Pfizer Inc.
  • Roche Holding AG
  • Novartis AG
  • Sanofi S.A.
  • Johnson & Johnson
  • AstraZeneca plc
  • AbbVie Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • Bayer AG
  • Novo Nordisk A/S
  • Takeda Pharmaceutical Co. Ltd.
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • Allergan plc
  • Celgene Corporation
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

Historical Year 2019

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Infectious Disease Therapeutics Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Infectious Disease Therapeutics Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Infectious Disease Therapeutics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Infectious Disease Therapeutics Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Infectious Disease Therapeutics Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Infectious Disease Therapeutics Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Infectious Disease Therapeutics Market size was valued at USD 115 billion in 2019 and is poised to grow from USD 119.86 billion in 2023 to USD 166.97 billion by 2031, growing at a CAGR of 4.23% in the forecast period (2024-2031).

infectious disease therapeutics market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'GlaxoSmithKline plc', 'Merck & Co.', 'Pfizer Inc.', 'Roche Holding AG', 'Novartis AG', 'Sanofi S.A.', 'Johnson & Johnson', 'AstraZeneca plc', 'AbbVie Inc.', 'Amgen Inc.', 'Bristol-Myers Squibb Company', 'Eli Lilly and Company', 'Gilead Sciences, Inc.', 'Bayer AG', 'Novo Nordisk A/S', 'Takeda Pharmaceutical Co. Ltd.', 'Biogen Inc.', 'Boehringer Ingelheim GmbH', 'Allergan plc', 'Celgene Corporation'

Increased spending to enhance the penetration rate of infectious disease treatments, rising strategies to raise awareness about treatments and diagnosis of these conditions, and increased clinical trial research for the development of new drugs may drive the growth of infectious disease therapeutics market over the forecast period.

Increasing prevalence of malaria disease in developing and underdeveloped countries including India, Africa, and other Southeast Asian countries, as well as increased research and development activities by key manufacturers and health care organisations, are all contributing to market development.

North America held the largest infectious disease therapeutics market share in 2021 due to the region's growing rate of infectious diseases. This region's large geriatric population has emerged as a significant growth factor for the market during the forecast period. People's increased disposable income has also become an important growth factor. The government's provision of advanced health-care facilities in the form of reimbursement policies has greatly aided market growth. Moreover, the existence of key manufacturers in the United States, as well as an increase in clinical trials for the introduction of new treatment drugs, are estimated to generate to this region's large market share.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Infectious Disease Therapeutics Market

Product ID: SQMIG35J2030

$5,300
BUY NOW GET FREE SAMPLE